Last reviewed · How we verify
Etacillin (HETACILLIN)
At a glance
| Generic name | HETACILLIN |
|---|---|
| Sponsor | Bristol-Myers Squibb |
| Drug class | hetacillin |
| Target | Penicillin-binding protein |
| Modality | Small molecule |
| Therapeutic area | Infectious Disease |
| Phase | FDA-approved |
| First approval | 1982 |
Approved indications
Common side effects
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Etacillin CI brief — competitive landscape report
- Etacillin updates RSS · CI watch RSS
- Bristol-Myers Squibb portfolio CI